Safety Surveillance through Antiretroviral Pregnancy Registry

Safety Surveillance through Antiretroviral Pregnancy Registry

Activity Dates: February 25, 2021 Estimated Time to complete activity: XX hours

1

This activity is jointly provided by Annenberg Health Sciences and the American Academy of HIV Medicine in collaboration with the Postgraduate Institute for Medicine.

This activity is supported by independent educational grants from Gilead Sciences, Janssen Therapeutics, and Merck Pharmaceuticals.

2

Speakers

? William R. Short, MD, MPH, AAHIVS Associate Professor of Medicine Perelman School of Medicine University of Pennsylvania

? Lynne Mofenson, MD Elizabeth Glaser Pediatric AIDS Foundation

? Angela Scheuerle, MD, FACMGG Professor of Pediatrics University of Texas Southwestern Medical Center

? Jessica Albano, PhD, MPH Syneos Health

3

Target Audience

This activity has been designed to meet the educational needs of physicians, physician assistants, nurse practitioners, pharmacists, and registered nurses; other healthcare providers, such as nutritionists, social workers, and case managers are also encouraged to attend.

Statement of Need/Program Overview

This webinar will be a lecture designed to impart a large amount of knowledge to participant supplemented with case studies to improve real time information about ARV use with pregnant women. In the US there are over six million pregnancies each year and pregnant women on average, take 3-5 prescriptions while pregnant. Women with preexisting conditions such as HIV may need to continue to take these medications during pregnancy and post-partum for breastfeeding. Providers need information regarding the use of prescriptions for women with HIV including: potential teratogenic effects and other short-and long-term adverse effects on fetuses or newborns including preterm birth, mutagenicity, and carcinogenicity, experience with use in pregnancy, drug-drug interactions, genotypic resistance testing and prior ART use, PK changes in pregnancy, potential maternal adverse effects, and comorbidities.

4

CE Information

Accreditation Statement This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and the American Academy of HIV Medicine. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

Physician Continuing Medical Education

The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

5

 ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download